Given such diversity, it is legitimate to ask whether any of them could be capable of generating new pandemics. Could the ...
Bronchoscopic lung volume reduction (BLVR) significantly improved lung function in a subset of patients with chronic ...
The CONVINCE trial of the anti-inflammatory drug colchicine missed its primary endpoint, but secondary analyses suggested ...
Low-income women with diabetes were less likely to receive adjuvant radiotherapy and chemotherapy to treat breast cancer, to ...
HOUSTON — Effective communication with patients isn't always easy, but Stacy Nigliazzo, RN, a clinical instructor at the ...
Medical autonomy on the athletic field is at the center of a trial that pits a former team doctor against college football ...
Children with concomitant atopic dermatitis (AD) and alopecia areata (AA) who were treated with dupilumab demonstrated ...
A new consensus guideline on the assessment and management of spasticity has been released. The American Academy of Physical ...
Dr Stephanie A Christenson highlights promising new therapeutic developments in COPD, signaling potential advancements in ...
At a recent diabetes conference, experts debated the relative merits of exercise and medication for weight loss in this ...
Dupilumab, a fully human monoclonal antibody, works by inhibiting the signaling of the interleukin 4 (IL-4) and interleukin ...
Highlights of macular degeneration research from ARVO 2024 include trial results of TRUCKEE on faricimab, GALE data on ...